AllSight
Companies · CBT · Miscellaneous Chemical Products

CABOT CORP (CBT)

CABOT CORP (CBT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

CABOT CORP (CBT) stock — financials & valuation

Key numbers for CABOT CORP (CBT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 49/100 — a percentile rank of CABOT CORP’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$3.9B
P / E20.5×
P / S1.1×
EV / EBITDA7.4×
Gross margin22.7%
Operating margin13.6%
Net margin6.3%
Return on equity12.0%
ROIC9.7%
Revenue growth-4.7%
Debt / equity0.8×
Dividend yield2.5%

Is CABOT CORP overvalued? P/E looks overvalued vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from CABOT CORP’s own financial statements and shown as context, never as advice.

Sep 15, 2026Interim CFO
Cabot names interim CFO as CEO transition leaves finance role open
Aug 21, 2026Debt refinanced
Cabot refinances $250M due 2026, extending maturities at a higher 4.95% coupon
Aug 14, 2026$350M notes due 2029
Cabot locks in $350M of new debt—without giving investors a payoff
Related companies in Miscellaneous Chemical Products
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact